29 results
8-K
MIRA
Mira Pharmaceuticals Inc
12 Jul 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
of the appeal process. There can be no assurance that the Company will regain compliance with the Minimum Bid Requirement during the 180-day compliance … compliance with the Minimum Bid Requirement and (ii) the Company’s testing and potential benefits of MIRA-55. There can be no assurance
10-K
2023 FY
EX-31.2
MIRA
Mira Pharmaceuticals Inc
1 Apr 24
Annual report
7:00am
reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding
10-K
2023 FY
MIRA
Mira Pharmaceuticals Inc
1 Apr 24
Annual report
7:00am
to complete the further development of our business plan, and there is no assurance that additional financing will be available or will be available … is uncertain and there is no assurance that our clinical development activities will meet the planned timelines set forth above.
Our Market Opportunity
10-K
2023 FY
EX-31.1
MIRA
Mira Pharmaceuticals Inc
1 Apr 24
Annual report
7:00am
, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding
8-K
1bvn8m 1l6ho
7 Mar 24
Other Events
4:45pm
8-K
EX-10.1
kbk61dgl7w4e
20 Nov 23
MIRA Pharmaceuticals Announces Exclusive Licensing Agreement for Oral Ketamine Analog, Ketamir-2
8:10am
8-K
EX-99.1
lv4juwhd48ojafaq9cg
20 Nov 23
MIRA Pharmaceuticals Announces Exclusive Licensing Agreement for Oral Ketamine Analog, Ketamir-2
8:10am
8-K
ot4e1ymuuu8l2g jk4do
20 Nov 23
MIRA Pharmaceuticals Announces Exclusive Licensing Agreement for Oral Ketamine Analog, Ketamir-2
8:10am
8-K
EX-10.3
pcunfiwmz7s2t58 mot
20 Nov 23
MIRA Pharmaceuticals Announces Exclusive Licensing Agreement for Oral Ketamine Analog, Ketamir-2
8:10am
10-Q
vlvt9iexac
15 Sep 23
Quarterly report
4:45pm
8-K
EX-1.1
vk3bkv
7 Aug 23
MIRA Pharmaceuticals, Inc. Announces Pricing of $8.9 Million Initial
5:14pm
424B4
nyvdlzlarg83
4 Aug 23
Prospectus supplement with pricing info
1:01pm
424B1
sur1sl18rbkr
4 Aug 23
Prospectus with pricing info
12:59pm